Indian Pharmaceuticals & Biotech Healthy potentially undervalued

Results

1 new

Companies which are potentially undervalued and in an acceptable financial position.

2 companies

Alembic Pharmaceuticals

Market Cap: ₹160.8b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

APLLTD

₹818.30

6.1%

-18.8%

Piramal Pharma

Market Cap: ₹223.5b

Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

PPLPHARMA

₹168.29

0.4%

-16.9%